Orion Biotechnology
About:
Orion Biotechnology is a clinical stage biotechnology company developing novel medical treatments.
Website: https://orionbiotechnology.com
Top Investors: Keiretsu Capital, Side Door Ventures, Keiretsu Forum, National Center for Research & Development, SevenTrainVentures
Description:
Orion Biotechnology is developing a pipeline of best-in-class biologic therapeutics based on Chemokine Analogue inhibitors, for the treatment of a broad range of serious unmet medical needs.
Total Funding Amount:
$14.2M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Ottawa, Ontario, Canada
Founded Date:
2011-01-01
Founders:
Rudolf Bom
Number of Employees:
11-50
Last Funding Date:
2024-07-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai